Formin protein FMNL1 is a biomarker for tumor-infiltrating immune cells and associated with well immunotherapeutic response

Lu, Guomin; Wang, Hui; Xu, Rui; Xu, Junying; An, Fangmei; Xu, Haoran; Nie, He; Mei, Jie; Zhan, Qiang; Zhang, Qinglin

doi:10.7150/jca.86965



International Journal of Biological Sciences

International Journal of Medical Sciences

Theranostics

Journal of Genomics

Nanotheranostics

Global reach, higher impact

Full Text | PDF

J Cancer 2023; 14(16):2978-2989. doi:10.7150/jca.86965 This issue Cite

Research Paper

Formin protein FMNL1 is a biomarker for tumor-infiltrating immune cells and associated with well immunotherapeutic response

Guomin Lu^1#, Hui Wang^1#, Rui Xu^2#, Junying Xu³, Fangmei An¹, Haoran Xu¹, He Nie¹, Jie Mei^3✉, Qiang Zhan^1✉, Qinglin Zhang^1✉

1. Departments of Gastroenterology, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi Medical Center, Nanjing Medical University, Wuxi, Jiangsu 214023, China.
2. The First College of Clinical Medicine, Nanjing Medical University, Nanjing, Jiangsu 211166, China.
3. Departments of Oncology, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi Medical Center, Nanjing Medical University, Wuxi, Jiangsu 214023, China.
^#Guomin Lu, Hui Wang, and Rui Xu contributed equally to this study.

✉ Corresponding authors: Jie Mei, Departments of Oncology, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi Medical Center, Nanjing Medical University, No. 299, Qingyang Road, Wuxi, Jiangsu 214023, China. E-mail: meijie1996edu.cn. Qiang Zhan, Departments of Gastroenterology, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi Medical Center, Nanjing Medical University, No. 299, Qingyang Road, Wuxi, Jiangsu 214023, China. E-mail: ryzhanqiangcom. Qinglin Zhang, Departments of Gastroenterology, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi Medical Center, Nanjing Medical University, No. 299, Qingyang Road, Wuxi, Jiangsu 214023, China. E-mail: zhang517068com. More

Citation:

Lu G, Wang H, Xu R, Xu J, An F, Xu H, Nie H, Mei J, Zhan Q, Zhang Q. Formin protein FMNL1 is a biomarker for tumor-infiltrating immune cells and associated with well immunotherapeutic response. J Cancer 2023; 14(16):2978-2989. doi:10.7150/jca.86965. https://www.jcancer.org/v14p2978.htm

Other styles

Abstract

Background: Increased studies on the basis of bulk RNA-sequencing (RNA-seq) data of cancer identify numbers of immune-related genes which may play potential regulatory roles in the tumor microenvironment (TME) without in-depth validation.

Methods: In the current study, the immunological correlation and cell subpopulation expression pattern of FMNL1 were analyzed using public data. In addition, the cell subpopulation expression pattern of FMNL1 was also deeply validated using single-cell RNA-sequencing (scRNA-seq) and multiplexed quantitative immunofluorescence (mQIF).

Results: Bulk FMNL1 mRNA was related to better prognosis in hepatocellular carcinoma (HCC) and was able to identify immuno-hot tumor in not only HCC but also multiple cancer types. Bulk FMNL1 mRNA also predicted the response to immunotherapy in multiple cancers. Further validation using scRNA-seq and mQIF revealed that FMNL1 was a biomarker for immune cells.

Conclusions: FMNL1 is a biomarker for immune cells in not only hepatocellular carcinoma, but also multiple cancer types. Moreover, immune infiltration analysis using the bulk RNA-seq data would be further validated using scRNA-seq and/or mQIF to describe the cell subpopulation expression pattern in tumor tissues for more in-depth and appropriate understanding.

Keywords: FMNL1, bioinformatics, biomarker, cancer, mQIF

Citation styles

APA

Lu, G., Wang, H., Xu, R., Xu, J., An, F., Xu, H., Nie, H., Mei, J., Zhan, Q., Zhang, Q. (2023). Formin protein FMNL1 is a biomarker for tumor-infiltrating immune cells and associated with well immunotherapeutic response. Journal of Cancer, 14(16), 2978-2989. https://doi.org/10.7150/jca.86965.

ACS

Lu, G.; Wang, H.; Xu, R.; Xu, J.; An, F.; Xu, H.; Nie, H.; Mei, J.; Zhan, Q.; Zhang, Q. Formin protein FMNL1 is a biomarker for tumor-infiltrating immune cells and associated with well immunotherapeutic response. J. Cancer 2023, 14 (16), 2978-2989. DOI: 10.7150/jca.86965.

NLM

CSE

Lu G, Wang H, Xu R, Xu J, An F, Xu H, Nie H, Mei J, Zhan Q, Zhang Q. 2023. Formin protein FMNL1 is a biomarker for tumor-infiltrating immune cells and associated with well immunotherapeutic response. J Cancer. 14(16):2978-2989.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.